Complete remission rates with 7 + 3 are about 70 to 85% (favorable genetics), 60 to 75% (intermediate genetics), and 25 to 40% (adverse genetics); complete remission rates also depend on patient-specific and other disease risk factors (eg, secondary vs de novo AML).